Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Andres Noyola-Perez, Alejandra J. Osuna-Corrales, Manali I. Patel, Jorge Cortes, Lillian Sung, Juan C. Angulo-Lozano, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 494.

https://doi.org/10.1182/blood-2023-189576

Published: 2023

Journal Articles

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

María de Lourdes Pastelín-Martínez, Moisés Manuel Gallardo-Pérez, Andres Gomez-De Leon, Juan Carlos Olivares-Gazca, Edgar Jared Hernández-Flores, Daniela Sánchez-Bonilla, Merittzel Abigail Montes-Robles, Max Robles-Nasta, Guillermo Ocaña-Ramm, Silvia Soto-Olvera, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 3593.

https://doi.org/10.1182/blood-2023-181433

Published: 2023

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Juan Carlos Olivares-Gazca, María de Lourdes Pastelín-Martínez, Merittzel Abigail Montes-Robles, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, Max Robles-Nasta, Daniela Sánchez-Bonilla, César Homero Gutierrez-Aguirre, Andres Gomez-De Leon, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2023-181489

Published: 2023

Journal Articles

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Perla R.R. Colunga-Pedraza, Andres Gomez-De Leon, Christianne Bourlon De Los Rios, Cesar Omar Vargas-Serafin, Myrna Patricia Pequeño Luevano, Lauro Fabian Amador, Carolina García-Castillo, Martha Alvarado, Guillermo José Ruiz-Argüelles, Alberto Olaya-Vargas, Samantha P. Peña-Lozano, Guadalupe González Villarreal, Elías Eugenio González López, Gabriela Cardoso Yah, Ivan Murrieta-Alvarez, Luis Mario Villela Martinez, David Gomez Almaguer

Blood (2022) 140 (Supplement 1): 5185–5187.

https://doi.org/10.1182/blood-2022-169096

Published: 2022

Journal Articles

Identification of Biomarkers As Predictors of Patient-Reported Outcomes in Persons with Multiple Sclerosis Given Autologous Hematopoietic Stem Cell Transplantation

Moisés Manuel Gallardo-Pérez, Javier Garcés-Eisele, Guillermo José Ruiz-Argüelles

Blood (2022) 140 (Supplement 1): 4855.

https://doi.org/10.1182/blood-2022-163765

Published: 2022

Journal Articles

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Juan Carlos Olivares-Gazca, Daniela Sánchez-Bonilla, José Antonio Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Moisés Manuel Gallardo-Pérez, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Argüelles

Blood (2022) 140 (Supplement 1): 1178–1179.

https://doi.org/10.1182/blood-2022-163740

Published: 2022

Journal Articles

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Yadith Karina Lopez-Garcia, Christianne Bourlon De Los Rios, Perla Rocio Colunga-Pedraza, Cesar Omar Vargas-Serafin, Alberto Vazquez Mellado de Larracoechea, Lourdes Gil-Flores, Nidia Moncada Saucedo, Moisés Manuel Gallardo-Pérez, David Gomez-Almaguer, Guillermo José Ruiz-Argüelles, Andres Gomez-De Leon

Blood (2022) 140 (Supplement 1): 2419–2420.

https://doi.org/10.1182/blood-2022-167805

Published: 2022

Journal Articles

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Elizabeth García-Villaseñor, Jorge E. Cortes, Oscar A. Reyes-Cisneros, José Antonio Fernández-Gutiérrez, Daniela Sánchez-Bonilla, Lorena Bojalil-Álvarez, Iván Murrieta-Álvarez, Guillermo José Ruiz-Delgado, Guillermo José Ruiz Argüelles

Blood (2022) 140 (Supplement 1): 11590–11591.

https://doi.org/10.1182/blood-2022-163602

Published: 2022

Journal Articles

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Olga Cantu Rodriguez, MD, Miguel Herrera-Rojas, MD, Andrea Garza-Acosta, MD, Cesar Homero Gutierrez Aguirre, Perla Rocio Colunga Pedraza, MD, Jose Jaime, MD, Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 4848.

https://doi.org/10.1182/blood.V130.Suppl_1.4848.4848

Published: 2017

Journal Articles

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, Juan Carlos Olivares Gazca, MD, Ivan Murrieta-Alvarez, MD, David Blumenkron-Marroquin, MD, Elias Eugenio Gonzalez-Lopez, MD, Alejandro Ruiz-Argüelles, MD, Guillermo Jose Ruiz-Delgado, Jr., MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 3290.

https://doi.org/10.1182/blood.V130.Suppl_1.3290.3290

Published: 2017

NARROW

Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go

Autologous HSCT for Multiple Sclerosis Should be Done Early in the Course of the Disease

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Identification of Biomarkers As Predictors of Patient-Reported Outcomes in Persons with Multiple Sclerosis Given Autologous Hematopoietic Stem Cell Transplantation

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Front-Line Treatment in Immune Thrombocytopenia Using Eltrombopag and High-Doses of Dexamethasone, Long-Term Follow-up

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only